SCHEMBL24953182

SCHEMBL24953182

Cc1n[nH]c(C)c1CCCOc1cc(C=O)ccc1F

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 4/20 0.67
▸ ALB P02768 1/20 0.67
▸ HSD17B10 Q99714 8/20 0.52
▸ SMN1; SMN2 Q16637 7/20 0.52
▸ MAPT P10636 5/20 0.52
▸ GAA P10253 1/20 0.52
▸ LMNA P02545 6/20 0.49
▸ MEN1 O00255 5/20 0.49
▸ KMT2A Q03164 5/20 0.49
▸ HTT P42858 4/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ MAPK1 P28482 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20463047 0.84 TTR (0.64) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL15828247 0.84 TTR (0.71) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL20145409 0.80 TTR (0.69) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL21618544 0.80 TTR (0.62) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL24953188 0.80 TTR (0.83) TTRALBHSD17B10SMN1; SMN2MAPT
Acoramidis SCHEMBL15816954 0.80 TTR (1.00) TTRALBHSD17B10SMN1; SMN2MAPT
Acoramidis SCHEMBL20475239 0.79 TTR (0.98) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL15816998 0.79 TTR (0.81) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL15158388 0.78 TTR (1.00) TTRALBHSD17B10SMN1; SMN2MAPT
SCHEMBL25129906 0.78 TTR (0.62) TTRALBHSD17B10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009612-A1 ACORAMIDIS (3-(3-(3,5-DIMETHYL-1H-PYRAZOL-4-YL)PROPOXY)-4-FLUOROBENZOIC ACID) DERIVATIVES FOR STABILIZING TRANSTHYRETIN (TTS) AND INHIBITING TTS MISFOLDING FOR THE TREATMENT OF E.G. PERIPHERAL TTR AMYLOIDOSIS PROTEGO BIOPHARMA, INC. (US) 2023-02-02 — — WO disclosed
Send feedback